NBIX

Neurocrine Biosciences (NBIX) Lifts INGREZZA Guidance, Is The Pullback A Bargain?

Stifel raises Neurocrine Bio stock price target on strong earnings

Neurocrine Biosciences, Inc. Stock 12‑Month Price Target Raised to $209.63, Implies 13% Upside

Needham raises Neurocrine Bio stock price target on strong quarter

Guggenheim raises Neurocrine Bio stock price target on Ingrezza beat

Neurocrine Biosciences director Leslie Norwalk sells $227,507 in stock

Neurocrine (NBIX) Reports Q2 Earnings: What Key Metrics Have to Say

Neurocrine Biosciences (NBIX) Surpasses Q2 Earnings and Revenue Estimates

Neurocrine Biosciences Reports Second-Quarter 2026 Financial Results

Neurocrine (NBIX) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

Neurocrine Biosciences stock hits all-time high at 181.3 USD

Neurocrine Gears Up to Report Q2 Earnings: What's in the Cards?

Neurocrine Biosciences (NBIX) Stock Trades Fair On Earnings But Mixed On Value

Neurocrine Biosciences Appoints Samir Siddhanti Chief Business Officer

Zacks.com featured highlights include NVIDIA, Neurocrine Biosciences and Ball